Mayerhoefer ME - Search Results

1

First-in-human response of BCL-2 inhibitor venetoclax in T-cell prolymphocytic leukemia.

Boidol B, Kornauth C, van der Kouwe E, Prutsch N, Kazianka L, Gültekin S, Hoermann G, Mayerhoefer ME, Hopfinger G, Hauswirth A, Panny M, Aretin MB, Hilgarth B, Sperr WR, Valent P, Simonitsch-Klupp I, Moriggl R, Merkel O, Kenner L, Jäger U, Kubicek S, Staber PB. Boidol B, et al. Among authors: mayerhoefer me. Blood. 2017 Dec 7;130(23):2499-2503. doi: 10.1182/blood-2017-05-785683. Epub 2017 Sep 27. Blood. 2017. PMID: 28972014 Free article.

2

Does Delayed-Time-Point Imaging Improve 18F-FDG-PET in Patients With MALT Lymphoma?: Observations in a Series of 13 Patients.

Mayerhoefer ME, Giraudo C, Senn D, Hartenbach M, Weber M, Rausch I, Kiesewetter B, Herold CJ, Hacker M, Pones M, Simonitsch-Klupp I, Müllauer L, Dolak W, Lukas J, Raderer M. Mayerhoefer ME, et al. Clin Nucl Med. 2016 Feb;41(2):101-5. doi: 10.1097/RLU.0000000000001005. Clin Nucl Med. 2016. PMID: 26402137 Free PMC article.

3

Long-term safety and activity of cladribine in patients with extranodal B-cell marginal zone lymphoma of the mucosa-associated lymphoid tissue (MALT) lymphoma.

Kiesewetter B, Dolak W, Simonitsch-Klupp I, Mayerhoefer ME, Raderer M. Kiesewetter B, et al. Among authors: mayerhoefer me. Hematol Oncol. 2017 Jun;35(2):177-186. doi: 10.1002/hon.2271. Epub 2015 Nov 18. Hematol Oncol. 2017. PMID: 26580149

4

Delayed Efficacy After Treatment With Lenalidomide or Thalidomide in Patients With Mucosa-Associated Lymphoid Tissue Lymphoma.

Kiesewetter B, Troch M, Mayerhoefer ME, Dolak W, Simonitsch-Klupp I, Raderer M. Kiesewetter B, et al. Among authors: mayerhoefer me. Oncologist. 2016 Jan;21(1):72-5. doi: 10.1634/theoncologist.2015-0176. Epub 2015 Nov 30. Oncologist. 2016. PMID: 26621040 Free PMC article.

5

18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.

Giraudo C, Raderer M, Karanikas G, Weber M, Kiesewetter B, Dolak W, Simonitsch-Klupp I, Mayerhoefer ME. Giraudo C, et al. Among authors: mayerhoefer me. Invest Radiol. 2016 Mar;51(3):163-9. doi: 10.1097/RLI.0000000000000218. Invest Radiol. 2016. PMID: 26784400 Free PMC article.

6

Gender Aspects in Extranodal Marginal Zone B-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue: Does Sex Matter?

Kiesewetter B, Lukas J, Dolak W, Simonitsch-Klupp I, Mayerhoefer ME, Raderer M. Kiesewetter B, et al. Among authors: mayerhoefer me. Oncology. 2016;91(5):243-250. doi: 10.1159/000448218. Epub 2016 Aug 23. Oncology. 2016. PMID: 27548082

7

Can Interim 18F-FDG PET or Diffusion-Weighted MRI Predict End-of-Treatment Outcome in FDG-Avid MALT Lymphoma After Rituximab-Based Therapy?: A Preliminary Study in 15 Patients.

Mayerhoefer ME, Karanikas G, Kletter K, Kiesewetter B, Weber M, Rausch I, Pones M, Simonitsch-Klupp I, Müllauer L, Dolak W, Lukas J, Raderer M. Mayerhoefer ME, et al. Clin Nucl Med. 2016 Nov;41(11):837-843. doi: 10.1097/RLU.0000000000001395. Clin Nucl Med. 2016. PMID: 27648705

8

Evaluation of [18F]-FDG-Based Hybrid Imaging Combinations for Assessment of Bone Marrow Involvement in Lymphoma at Initial Staging.

Asenbaum U, Nolz R, Karanikas G, Furtner J, Woitek R, Staudenherz A, Senn D, Raderer M, Weber M, Simonitsch-Klupp I, Mayerhoefer ME. Asenbaum U, et al. Among authors: mayerhoefer me. PLoS One. 2016 Oct 10;11(10):e0164118. doi: 10.1371/journal.pone.0164118. eCollection 2016. PLoS One. 2016. PMID: 27723817 Free PMC article.

9

A phase 2 study of rituximab plus lenalidomide for mucosa-associated lymphoid tissue lymphoma.

Kiesewetter B, Willenbacher E, Willenbacher W, Egle A, Neumeister P, Voskova D, Mayerhoefer ME, Simonitsch-Klupp I, Melchardt T, Greil R, Raderer M; AGMT Investigators. Kiesewetter B, et al. Among authors: mayerhoefer me. Blood. 2017 Jan 19;129(3):383-385. doi: 10.1182/blood-2016-06-720599. Epub 2016 Nov 22. Blood. 2017. PMID: 27879257 Free article. Clinical Trial. No abstract available.

10

A pilot phase II study of ofatumumab monotherapy for extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT) lymphoma.

Kiesewetter B, Neuper O, Mayerhoefer ME, Dolak W, Lukas J, Simonitsch-Klupp I, Raderer M. Kiesewetter B, et al. Among authors: mayerhoefer me. Hematol Oncol. 2018 Feb;36(1):49-55. doi: 10.1002/hon.2454. Epub 2017 Jul 10. Hematol Oncol. 2018. PMID: 28695630 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

145 results

Search Page